A PE deal values Intas at Rs 23,000 crore or USD 3.5 billion, making it the most valued pharma privately held company in India. ...http://www.moneycontrol.com/news/business/intas-pharma-becomes-most-valuable-privately-held-pharma-company_8729021.html
Intas said it is undertaking a detailed analysis on reports of inflammation and has advised doctors to avoid using the product, meant to treat an... ...http://www.moneycontrol.com/news/business/exclusive-complaints-prompt-intas-to-recall-batchbiosimilar-razumabindia_8725721.html
Direct investments made overseas by Indian companies declined 57.3 per cent to USD 1.82 billion last month, the Reserve Bank data showed today. The... ...http://www.business-standard.com/article/pti-stories/india-inc-s-fdi-overseas-down-57-to-1-82-bn-117021300482_1.html
we are leading traders...